Condition: Healthy Aging · Anti Aging · Sponsor: Synbiotic Health
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
This description comes directly from the study's public registry record.
Shalini Jain, PhD · 813-419-0781 · jains@musbresearch.com
Indushekar Manjunatha · imanjunatha@musbresearch.com
Always discuss trial participation with your own doctor first.
| MusB Research LLC | New Port Richey, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07407894